Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Group A and C meningococcal polysaccharide vaccine post-marketing immunogenicity and safety
CTR20150404Phase 4Completed
- Sponsor
- Beijing Luzhu Biotechnology
- Start
- Jun 2015
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of unconjugated meningococcal polysaccharide vaccine (serogroups A, C) in meningococcal meningitis, sponsored by Beijing Luzhu Biotechnology. Started Jun 2015; status: completed.
02
Drugs
unconjugated meningococcal polysaccharide vaccine (serogroups A, C)
03
Conditions
meningococcal meningitis
Beyond the preview
Go deeper on CTR20150404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150404.